Granisetron Hydrochloride Tablet
Product Images NDC 51991-735

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Granisetron Hydrochloride (NDC 51991-735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Granisetron 01)

Chemical Structure (Granisetron 01)
Chemical structure of Granisetron Hydrochloride depicted with molecular formula showing the arrangement of atoms including a bicyclic structure and a hydrochloride salt component.*
FDA Label Image

Principal Display Panel (2 Tablet Blister Pack Carton)

Principal Display Panel (2 Tablet Blister Pack Carton)
Packaging label for Granisetron Hydrochloride Tablets, USP 1 mg per tablet. The label indicates the product is supplied as two 1 mg tablets in a unit-dose package. The labeler is Breckenridge Pharmaceutical, Inc. The label includes dosage instructions, storage conditions, manufacturer information (Natco Pharma Limited, India), and a barcode. The package is marked Rx only and is not child-resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.